Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is completed. It focuses on schizophrenia and currently lists study information in Argentina, Austria, Belgium, Brazil, Bulgaria, China, Czech Republic, Denmark, Finland, Germany, Lithuania, Mexico, Portugal, Serbia, South Korea, Taiwan, the United Kingdom, and the United States.
Multiple locations, including AnaheimThis study was withdrawn in Global. It focuses on PTSD.
In Global
This study is active but not recruiting. It focuses on PTSD and currently lists study information in the United States.
In TempleThis study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In La JollaThis study is completed. It focuses on schizophrenia and currently lists study information in the United States.
In TulsaThis study is completed. It focuses on depression and currently lists study information in the United States.
In SeattleThis study is completed. It focuses on depression and currently lists study information in the United States.
In SeattleThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In DurhamThis study is completed. It focuses on PTSD and currently lists study information in the United States.
In BaltimoreThis study is completed. It focuses on ADHD and currently lists study information in the United States.
In Ann ArborThis study has public registry information. It focuses on schizophrenia and currently lists study information in Canada.
In Vancouver
This study is active but not recruiting. It focuses on bipolarity and currently lists study information in France.
In ÉtampesHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.